NALTREXONE HYDROCHLORIDE TABLETS USP

sterinova inc.🇨🇦 Health Canada

Approval Id: 47044c37b09f4bb2
Drug Approval Canada Name: NALTREXONE HYDROCHLORIDE TABLETS USP
Product Name: NALTREXONE HYDROCHLORIDE TABLETS USP
Status: Marketed
Status Date: 2017-05-30
Original Market Date: 2017-05-30
Din: 02451883
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:10.00
Atc Original: N07BB04 NALTREXONE
Atc Name: n 07 bb 04
Aig Number: 0118591001
Company Name: sterinova inc.
Company Address: 3005 Avenue Jose-Maria Rosell, Saint-Hyacinthe, Quebec, Canada, J2S 0J9

NALTREXONE HYDROCHLORIDE

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

47044c37b09f4bb2

Type

Standard